Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
153M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
16.8M
-
Shares change
-
+175K
-
Total reported value, excl. options
-
$20.7M
-
Value change
-
+$99.2K
-
Number of buys
-
12
-
Number of sells
-
-9
-
Price
-
$1.23
Significant Holders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) as of Q2 2023
31 filings reported holding BDSX - BIODESIX INC - Common Stock, par value $0.001 per share as of Q2 2023.
BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.8M shares
of 153M outstanding shares and own 10.99% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (5.06M shares), Birchview Capital, LP (5.04M shares), VANGUARD GROUP INC (1.29M shares), Worth Venture Partners, LLC (1.26M shares), ESSEX INVESTMENT MANAGEMENT CO LLC (1.03M shares), WELLS FARGO & COMPANY/MN (843K shares), BlackRock Inc. (409K shares), GEODE CAPITAL MANAGEMENT, LLC (370K shares), Legato Capital Management LLC (354K shares), and STATE STREET CORP (275K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.